Dechra Pharmaceuticals PLC (GB:DPH)

Dechra Pharmaceuticals (DPH) Share Price & Analysis


DPH Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range2,446.04p - 4,145.84p
Previous Close3,804p
Average Volume (3M)1.22M
Market Cap
Enterprise Value475.56B
Total Cash (Recent Filing)$87.90M
Total Debt (Recent Filing)$511.20M
Price to Earnings (P/E)105.3
Feb 26, 2024
EPS EstimateN/A
0.45 (0.01%)
Share Statistics
EPS (TTM)0.36
Shares Outstanding113,824,190
10 Day Avg. Volume360,330
30 Day Avg. Volume1,220,088
Standard Deviation0.08
Financial Highlights & Ratios
Price to Book (P/B)-1604.94
Price to Sales (P/S)1096.02
Price to Cash Flow (P/CF)4199.30
P/FCF Ratio5683.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.24K
Enterprise Value/EbitdaN/A
Price Target Upside1.87% Upside
Rating ConsensusHold
Number of Analyst Covering1




What was Dechra Pharmaceuticals PLC’s price range in the past 12 months?
Dechra Pharmaceuticals PLC lowest share price was 2446.04p and its highest was 4145.84p in the past 12 months.
    What is Dechra Pharmaceuticals PLC’s market cap?
    Currently, no data Available
    When is Dechra Pharmaceuticals PLC’s upcoming earnings report date?
    Dechra Pharmaceuticals PLC’s upcoming earnings report date is Feb 26, 2024 which is in 155 days.
      How were Dechra Pharmaceuticals PLC’s earnings last quarter?
      Currently, no data Available
      Is Dechra Pharmaceuticals PLC overvalued?
      According to Wall Street analysts Dechra Pharmaceuticals PLC’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Dechra Pharmaceuticals PLC pay dividends?
        Dechra Pharmaceuticals PLC pays a Annually dividend of 12.5p which represents an annual dividend yield of 1.19%. See more information on Dechra Pharmaceuticals PLC dividends here
          What is Dechra Pharmaceuticals PLC’s EPS estimate?
          Dechra Pharmaceuticals PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Dechra Pharmaceuticals PLC have?
          Dechra Pharmaceuticals PLC has 113,888,300 shares outstanding.
            What happened to Dechra Pharmaceuticals PLC’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Dechra Pharmaceuticals PLC?
            Currently, no hedge funds are holding shares in GB:DPH


            Dechra Pharmaceuticals Stock Smart Score

            The Dechra Pharmaceuticals Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
            Learn more about TipRanks Smart Score

            Company Description

            Dechra Pharmaceuticals PLC

            Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.


            Top 5 ETFs holding DPH

            Market Value
            Smart Score
            dbxt FTSE ALL-S Shs -1D- Distribution
            Lyxor Core UK Equity All Cap (DR) UCITS ETF
            UBS ETF FTSE100 Shs -A- Distribution
            dbxt FTSE 100 Shs -1D- Distribution
            dbxt FTSE 100 U Shs -1C- Capitalisation
            Up to five ETFs with an Outperform Smart Score that hold DPH. The ETFs are listed according to market value of DPH within the ETF

            Forecast EPS vs Actual EPS

            Currently, no data available
            Please return soon. This page is being updated.

            Similar Stocks
            Price & Change
            Hikma Pharmaceuticals
            Futura Medical

            Popular Stocks

            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis